Answers are grounded in this paper and cite their sources.
Thrombosis and restenosis remain major challenges for vascular implants, motivating the development of biomaterials that integrate anticoagulant activity with complementary vascular biofunctions. Here, a dual-functionalized silk fibroin (SF)-based hydrogel was developed via a one-pot 1-ethyl-3-(3-(dimethylamino)propyl)carbodiimide (EDC)/N-hydroxysuccinimide (NHS)-mediated conjugation of heparin and selenocystamine (SeCA). The resulting SF-heparin-SeCA conjugate can be further cross-linked into a hydrogel network through enzymatic dityrosine formation under mild, room-temperature conditions. Within the hydrogel, heparin provides anticoagulant activity, while SeCA catalyzes nitric oxide (NO) generation from ph ysiological S-nitrosothiol donors, such as S-nitrosoglutathione (GSNO), thereby integrating complementary anticoagulant and NO-generating functions within a single SF-based platform. The hydrogel exhibited distinct physicochemical and mechanical properties, sustained NO-generating capability, and enhanced anticoagulant performance. Collectively, these findings establish a streamlined strategy for integrating anticoagulant and NO-generating functions within an SF-based hydrogel and support its potential for blood-contacting vascular applications.
No takes yet. Share an insight, caveat, or question.
Ji et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: